(19)
(11) EP 2 294 177 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.12.2016 Bulletin 2016/51

(45) Mention of the grant of the patent:
19.10.2016 Bulletin 2016/42

(21) Application number: 09759521.9

(22) Date of filing: 05.06.2009
(51) International Patent Classification (IPC): 
C12M 1/32(2006.01)
C12M 1/34(2006.01)
 C12M 1/12(2006.01)
G01N 33/50(2006.01)
(86) International application number:
PCT/US2009/046431
(87) International publication number:
WO 2009/149363 (10.12.2009 Gazette 2009/50)

(54)

THREE DIMENSIONAL TISSUES FOR HIGH-THROUGHPUT ASSAYS

DREIDIMENSIONALE GEWEBE FÜR TESTVERFAHREN MIT HOHEM DURCHSATZ

TISSUS TRIDIMENSIONNELS POUR DOSAGE À HAUT RENDEMENT

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 05.06.2008 US 59126

(43) Date of publication of application:
16.03.2011 Bulletin 2011/11

(60) Divisional application:
16194426.9

(73) Proprietor: InvivoSciences, Inc.
McFarland WI 53558 (US)

(72) Inventor:
  • WAKATSUKI, Tetsuro
    Milwaukee WI 53226 (US)

(74) Representative: Watson, Robert James et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)


(56) References cited: : 
WO-A1-00/69355
WO-A1-98/38490
WO-A2-2005/039396
US-A1- 2003 064 358
US-B1- 6 881 584
 WO-A1-01/11340
WO-A2-03/016860
US-A- 5 843 766
US-A1- 2008 038 812
   
  • WAKATSUKI T ET AL: "PHENOTYPIC SCREENING FOR PHARMACEUTICALS USING TISSUE CONSTRUCTS", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, BENTHAM SCIENCE PUBLISHERS, NL, vol. 5, no. 2, 1 April 2004 (2004-04-01), pages 181-189, XP001204950, ISSN: 1389-2010, DOI: 10.2174/1389201043376940
  • BILSLAND J ET AL: "A RAPID METHOD FOR SEMI-QUANTITATIVE ANALYSIS OF NEURITE OUTGROWTH FROM CHICK DRG EXPLANTS USING IMAGE ANALYSIS", JOURNAL OF NEUROSCIENCE METHODS, ELSEVIER SCIENCE PUBLISHER B.V., AMSTERDAM, NL, vol. 92, 15 October 1999 (1999-10-15), pages 75-85, XP000944375, ISSN: 0165-0270, DOI: 10.1016/S0165-0270(99)00099-0
  • ALLEN F D ET AL: "CALPAIN REGULATED CELL ADHESION IN EGF-STIMULATED FIBROBLAST-POPULATED-COLLAGEN-LATTICE CONTRACTION", BED, AMERICAN SOCIETY OF MECHANICAL ENGINEERS, US, vol. 50, 1 January 2001 (2001-01-01), page 353/354, XP009043345, ISSN: 1521-4613
  • ESCHENHAGEN T ET AL: "TRANSFECTION STUDIES USING A NEW CARDIAC 3D GEL SYSTEM", MOLECULAR APPROACHES TO HEART FAILURE THERAPY, XX, XX, 1 January 2000 (2000-01-01), pages 144-156, XP001204883,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).